Tori Rodriguez, MA, LPC, AHC

Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms.

In an expert roundtable, clinicians discuss the risks, benefits, and anticipated real-world usage of lecanemab following US FDA approval.

Robyn Tiger, MD, radiologist and founder of StressFreeMD, talks about physician burnout and strategies for addressing stress-related illness.

These are the clinical trials that led to the FDA’s approval of aducanumab and lecanemab for early AD, plus, the concerns that loom.

Mehdi Jorfi, PhD, discusses the opportunities to optimize the development and application of neurotechnologies for AD.

Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in ADRD and how to improve clinical outcomes for patients from underrepresented groups.

The polio strain linked to 2 paralytic polio cases in New York and Israel has been found in sewage water in New York City, London, and Jerusalem.

Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.

David Howell, PhD; and Heather Sesma, PhD; provide insight into the specific sequelae of concussion in youth and risk for subsequent mental health issues.

In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.

The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.

Studies show increased rate of all types of dementia in patients with AF, with new data finding treatment of AF lowers risk for cognitive dysfunction.

Researchers found data that showed, after consultation with an expert, optimal prevention of migraine headaches for patients who present in the emergency department includes both antiseizure medications, specifically, divalproex sodium, sodium valproate, or topiramate, and β-blockers, namely, metoprolol, propranolol, and timolol. In addition, triptans are suggested, as well as antidepressants, amitriptyline, and venlafaxine.

In an interview with Neurology Advisor, Robert Cowan, MD, FAAN explains how thunderclap headache may be the only early warning sign of vascular changes or brain injury.

Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.